![](/img/cover-not-exists.png)
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival
Philipp Schütt, Peter Ebeling, Ulrike Buttkereit, Dieter Brandhorst, Bertram Opalka, Miriam Poser, Siemke Müller, Michael Flasshove, Thomas Moritz, Siegfried Seeber, Mohammad Resa NowrousianVolume:
84
Language:
english
Pages:
7
DOI:
10.1007/s00277-005-1007-7
Date:
September, 2005
File:
PDF, 132 KB
english, 2005